Co-Authors
This is a "connection" page, showing publications co-authored by Martine Valette and Bruno Lina.
Connection Strength
1.054
-
Performance of influenza case definitions for influenza community surveillance: based on the French influenza surveillance network GROG, 2009-2014. Euro Surveill. 2017 Apr 06; 22(14).
Score: 0.178
-
Characterization of SARS-CoV-2 ORF6 deletion variants detected in a nosocomial cluster during routine genomic surveillance, Lyon, France. Emerg Microbes Infect. 2021 Dec; 10(1):167-177.
Score: 0.061
-
Live virus neutralization testing in convalescent patients and subjects vaccinated against 19A, 20B, 20I/501Y.V1 and 20H/501Y.V2 isolates of SARS-CoV-2. Emerg Microbes Infect. 2021 Dec; 10(1):1499-1502.
Score: 0.061
-
Bamlanivimab as monotherapy in two immunocompromised patients with COVID-19. Lancet Microbe. 2021 Sep; 2(9):e424.
Score: 0.060
-
Characteristics of the delayed respiratory syncytial virus epidemic, 2020/2021, Rhône Loire, France. Euro Surveill. 2021 07; 26(29).
Score: 0.060
-
Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70, France, August to December 2020. Euro Surveill. 2021 01; 26(3).
Score: 0.058
-
Evaluation of NGS-based approaches for SARS-CoV-2 whole genome characterisation. Virus Evol. 2020 Jul; 6(2):veaa075.
Score: 0.057
-
Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino acid deletion in nsp2 (Asp268del). Clin Microbiol Infect. 2020 07; 26(7):960-962.
Score: 0.055
-
Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis. 2020 06; 20(6):697-706.
Score: 0.055
-
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020. Euro Surveill. 2020 03; 25(9).
Score: 0.054
-
Quality control implementation for universal characterization of DNA and RNA viruses in clinical respiratory samples using single metagenomic next-generation sequencing workflow. BMC Infect Dis. 2018 Oct 29; 18(1):537.
Score: 0.050
-
Clinical management and viral genomic diversity analysis of a child's influenza A(H1N1)pdm09 infection in the context of a severe combined immunodeficiency. Antiviral Res. 2018 12; 160:1-9.
Score: 0.049
-
The NS Segment of H1N1pdm09 Enhances H5N1 Pathogenicity in a Mouse Model of Influenza Virus Infections. Viruses. 2018 09 17; 10(9).
Score: 0.049
-
Estimation of seasonal influenza vaccine effectiveness using data collected in primary care in France: comparison of the test-negative design and the screening method. Clin Microbiol Infect. 2018 Apr; 24(4):431.e5-431.e12.
Score: 0.046
-
Early estimates of 2016/17 seasonal influenza vaccine effectiveness in primary care in France. J Clin Virol. 2017 10; 95:1-4.
Score: 0.046
-
Characterization of oseltamivir-resistant influenza virus populations in immunosuppressed patients using digital-droplet PCR: Comparison with qPCR and next generation sequencing analysis. Antiviral Res. 2017 Sep; 145:160-167.
Score: 0.045
-
Surveillance of community-acquired viral infections due to respiratory viruses in Rhone-Alpes (France) during winter 1994 to 1995. J Clin Microbiol. 1996 Dec; 34(12):3007-11.
Score: 0.043
-
Genetic content of Influenza H3N2 vaccine seeds. PLoS Curr. 2010 Sep 05; 2:RRN1165.
Score: 0.028